List of Tables:
Table 1. Snapshot of North America Injectable Drugs Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Injectable Drugs Market 33
Table 5. North America Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 41
Table 6. North America Injectable Drugs Market by Drug Class, 2019-2030, $ bn 45
Table 7. North America Injectable Drugs Market by Delivery, 2019-2030, $ bn 55
Table 8. North America Injectable Drugs Market by Application, 2019-2030, $ bn 60
Table 9. North America Injectable Drugs Market by Distribution Channel, 2019-2030, $ bn 69
Table 10. North America Injectable Drugs Market by Country, 2019-2030, $ bn 75
Table 11. U.S. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 79
Table 12. U.S. Injectable Drugs Market by Drug Class, 2019-2030, $ bn 79
Table 13. U.S. Injectable Drugs Market by Application, 2019-2030, $ bn 79
Table 14. Canada Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 81
Table 15. Canada Injectable Drugs Market by Drug Class, 2019-2030, $ bn 81
Table 16. Canada Injectable Drugs Market by Application, 2019-2030, $ bn 81
Table 17. Mexico Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 83
Table 18. Mexico Injectable Drugs Market by Drug Class, 2019-2030, $ bn 83
Table 19. Mexico Injectable Drugs Market by Application, 2019-2030, $ bn 83
Table 20. Amgen Inc.: Company Snapshot 88
Table 21. Amgen Inc.: Business Segmentation 88
Table 22. Amgen Inc.: Product Portfolio 89
Table 23. Amgen Inc.: Revenue, 2018-2020, $ bn 89
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Injectable Drugs Market, 2019-2030, $ bn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Injectable Drugs Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 9. Primary Restraints and Impact Factors of North America Injectable Drugs Market 30
Figure 10. Investment Opportunity Analysis 34
Figure 11. Porters Fiver Forces Analysis of North America Injectable Drugs Market 37
Figure 12. Breakdown of North America Injectable Drugs Market by Molecule Type, 2019-2030, % of Revenue 42
Figure 13. North America Addressable Market Cap in 2021-2030 by Molecule Type, Value ($ bn) and Share (%) 42
Figure 14. North America Injectable Drugs Market by Molecule Type: Small Molecule, 2019-2030, $ bn 43
Figure 15. North America Injectable Drugs Market by Molecule Type: Large Molecule, 2019-2030, $ bn 44
Figure 16. Breakdown of North America Injectable Drugs Market by Drug Class, 2019-2030, % of Sales Revenue 46
Figure 17. North America Addressable Market Cap in 2021-2030 by Drug Class, Value ($ bn) and Share (%) 46
Figure 18. North America Injectable Drugs Market by Drug Class: Monoclonal Antibodies (mAbs), 2019-2030, $ bn 47
Figure 19. North America Injectable Drugs Market by Drug Class: Immunoglobulin, 2019-2030, $ bn 48
Figure 20. North America Injectable Drugs Market by Drug Class: Insulin, 2019-2030, $ bn 49
Figure 21. North America Injectable Drugs Market by Drug Class: Vaccines, 2019-2030, $ bn 50
Figure 22. North America Injectable Drugs Market by Drug Class: Cytokines, 2019-2030, $ bn 51
Figure 23. North America Injectable Drugs Market by Drug Class: Peptide Hormone, 2019-2030, $ bn 52
Figure 24. North America Injectable Drugs Market by Drug Class: Blood Factors, 2019-2030, $ bn 53
Figure 25. North America Injectable Drugs Market by Drug Class: Other Drug Classes, 2019-2030, $ bn 54
Figure 26. Breakdown of North America Injectable Drugs Market by Delivery, 2019-2030, % of Sales Revenue 56
Figure 27. North America Addressable Market Cap in 2021-2030 by Delivery, Value ($ bn) and Share (%) 56
Figure 28. North America Injectable Drugs Market by Delivery: Pre-filled Syringe, 2019-2030, $ bn 57
Figure 29. North America Injectable Drugs Market by Delivery: Infusions, 2019-2030, $ bn 58
Figure 30. North America Injectable Drugs Market by Delivery: Other Deliveries, 2019-2030, $ bn 59
Figure 31. Breakdown of North America Injectable Drugs Market by Application, 2019-2030, % of Revenue 61
Figure 32. North America Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 61
Figure 33. North America Injectable Drugs Market by Application: Oncology, 2019-2030, $ bn 62
Figure 34. North America Injectable Drugs Market by Application: Infectious Diseases, 2019-2030, $ bn 63
Figure 35. North America Injectable Drugs Market by Application: Autoimmune Diseases, 2019-2030, $ bn 64
Figure 36. North America Injectable Drugs Market by Application: Cardiovascular Diseases, 2019-2030, $ bn 65
Figure 37. North America Injectable Drugs Market by Application: Pain, 2019-2030, $ bn 66
Figure 38. North America Injectable Drugs Market by Application: Neurology, 2019-2030, $ bn 67
Figure 39. North America Injectable Drugs Market by Application: Other Applications, 2019-2030, $ bn 68
Figure 40. Breakdown of North America Injectable Drugs Market by Distribution Channel, 2019-2030, % of Revenue 70
Figure 41. North America Addressable Market Cap in 2021-2030 by Distribution Channel, Value ($ bn) and Share (%) 70
Figure 42. North America Injectable Drugs Market by Distribution Channel: Hospital Pharmacy, 2019-2030, $ bn 71
Figure 43. North America Injectable Drugs Market by Distribution Channel: Retail Pharmacy, 2019-2030, $ bn 72
Figure 44. North America Injectable Drugs Market by Distribution Channel: E-Commerce, 2019-2030, $ bn 73
Figure 45. Breakdown of North America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 75
Figure 46. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 76
Figure 47. U.S. Injectable Drugs Market, 2019-2030, $ bn 78
Figure 48. Canada Injectable Drugs Market, 2019-2030, $ bn 80
Figure 49. Injectable Drugs Market in Mexico, 2019-2030, $ bn 82
Figure 50. Growth Stage of North America Injectable Drugs Industry over the Forecast Period 84
